Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Vinuesa-Hernando JM"'
Initiation of lipid-lowering therapy as primary prevention of cardiovascular disease in the elderly.
Autor:
Vinuesa-Hernando JM; Pharmacy Service, Hospital Clinico Universitario Lozano Blesa, Zaragoza, Spain., Aguilar-Palacio I; Department of Preventive Medicine and Public Health, University of Zaragoza, Zaragoza, Spain.; Grupo de Investigación en Servicios Sanitarios de Aragón (GRISSA), Fundación Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, Spain.; Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), ISCIII, Madrid, Spain., Rabanaque MJ; Department of Preventive Medicine and Public Health, University of Zaragoza, Zaragoza, Spain.; Grupo de Investigación en Servicios Sanitarios de Aragón (GRISSA), Fundación Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, Spain.; Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), ISCIII, Madrid, Spain., García-Cárdenas V; Pharmacy and Pharmaceutical Technology Department, University of Granada, Granada, Spain., Lallana MJ; Grupo de Investigación en Servicios Sanitarios de Aragón (GRISSA), Fundación Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, Spain.; Primary Care Pharmacy Service, Sector Zaragoza III, Servicio Aragonés de Salud (SALUD), Zaragoza, Spain., Gamba A; Grupo de Investigación en Servicios Sanitarios de Aragón (GRISSA), Fundación Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, Spain., Malo S; Department of Preventive Medicine and Public Health, University of Zaragoza, Zaragoza, Spain.; Grupo de Investigación en Servicios Sanitarios de Aragón (GRISSA), Fundación Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, Spain.; Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), ISCIII, Madrid, Spain.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2024 Oct; Vol. 90 (10), pp. 2663-2672. Date of Electronic Publication: 2024 Jul 03.
Autor:
Vinuesa-Hernando JM; Pharmacy Department, Hospital Clínico Universitario Lozano Blesa, C/San Juan Bosco, Zaragoza, Spain. jmvinuesa@salud.aragon.es., Gimeno-Gracia M; Pharmacy Department, Hospital Clínico Universitario Lozano Blesa, C/San Juan Bosco, Zaragoza, Spain.; Aragon Institute for Health Research, Zaragoza, Spain., Malo S; Aragon Institute for Health Research, Zaragoza, Spain.; Microbiology, Preventive Medicine and Public Health Department, Universidad de Zaragoza, Zaragoza, Spain., Sanjoaquin-Conde I; Aragon Institute for Health Research, Zaragoza, Spain.; Infectious Diseases Department, Hospital Clínico Universitario Lozano Blesa, C/San Juan Bosco, Zaragoza, Spain., Crusells-Canales MJ; Aragon Institute for Health Research, Zaragoza, Spain.; Infectious Diseases Department, Hospital Clínico Universitario Lozano Blesa, C/San Juan Bosco, Zaragoza, Spain., Letona-Carbajo S; Aragon Institute for Health Research, Zaragoza, Spain.; Infectious Diseases Department, Hospital Clínico Universitario Lozano Blesa, C/San Juan Bosco, Zaragoza, Spain., Gracia-Piquer R; Pharmacy Department, Hospital Clínico Universitario Lozano Blesa, C/San Juan Bosco, Zaragoza, Spain.
Publikováno v:
International journal of clinical pharmacy [Int J Clin Pharm] 2021 Oct; Vol. 43 (5), pp. 1245-1250. Date of Electronic Publication: 2021 Feb 04.